Printer Friendly

AUDIOSCIENCE RECEIVES FDA APPROVAL

 AUDIOSCIENCE RECEIVES FDA APPROVAL
 MINNETONKA, Minn., July 31 /PRNewswire/ -- AudioScience, Inc.,


(NASDAQ: AUDS) today announced that it has received 510K approval for sale of its A2100 Programmable, remote controllable hearing system from the U.S. Food and Drug Administration. They said that this will enable the company to commence its Beta clinical sales.
 The AudioScience A2100 hearing system consists of a multi- environment, dual channel hearing instrument and a dual purpose remote control. The remote control allows the user to adjust the hearing instrument according to his or her individual listening needs for the selection of any of up to 10 custom settings. For the dispensing professional, the remote control becomes the programming tool for customizing the hearing system, when a special programming key is inserted.
 President Douglas Jensen said that having an A2100 hearing system is like having a set of 10 hearing instruments custom programmed for 10 different listening environments, that can be changed with the push of a button.
 AudioScience, Inc. is a development stage company which has designed and developed, manufactures and markets technologically advanced hearing instrument systems. The AudioScience mission is to be the technology leader in the development of medical devices for audiology, otolaryngology and the hearing health care market.
 -0- 7/31/92
 /CONTACT: Douglas Jensen or James L. Baustert, 612-936-0200, both of AudioScience/
 (AUDS) CO: AudioScience, Inc. ST: Minnesota IN: MTC SU:


AL -- MN013 -- 5791 07/31/92 17:18 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 31, 1992
Words:239
Previous Article:DELMARVA POWER BEGINS LEGAL PROCESS TO SET 1993 RATES
Next Article:AMERICAN FINANCIAL SERVICES ASSOCIATION RESPONDS TO NAAG'S STATEMENTS REGARDING PREEMPTION PROVISION IN CREDIT REPORTING BILL
Topics:


Related Articles
J. STEPHEN WEST APPOINTED TO AUDIOSCIENCE BOARD OF DIRECTORS
AUDIOSCIENCE NAMES NEW PRIMARY CHIP SUPPLIER, BEGINS IN-HOUSE TESTING OF NEW HEARING SYSTEM
AUDIOSCIENCE ANNOUNCES CLINICAL TESTING
AUDIOSCIENCE ANNOUNCES CLINICAL TESTING
AUDIOSCIENCE REPORTS FIRST QUARTER RESULTS
AUDIOSCIENCE REPORTS SECOND QUARTER RESULTS
AUDIOSCIENCE, INC. ANNOUNCES BETA CLINICAL SALES
AUDIOSCIENCE, INC. REPORTS THIRD QUARTER RESULTS
PROFESSIONAL DEVELOPMENT SEMINARS ANNOUNCED BY AUDIOSCIENCE
Urologix, Inc. PMA Satisfies FDA Initial Review

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters